UI Health

Home » Program

Subscribe for Newsletter

Polls

How Is The Site?

View Results

Loading ... Loading ...

Program

icon_track_field

Schedule

Download ISOBM Schedule

 

Registration and Exhibition Hours for ISOBM 2017

 

Location: Rendezvous Area

 

Registration Hours:

Wednesday, August 31: 3:00 PM – 9:00 PM

Thursday, September 1: 8:00 AM – 4:00 PM

Friday, September 2: 8:00 AM – 5:00 PM

Saturday, September 3: 8:00 AM – 4:00 PM

Sunday, September 4: 8:00 AM – 5:00 PM

Monday, September 5: 8:00 AM – 5:00 PM

Tuesday, September 6: 8:00 AM – 11:00 AM

 

Exhibition Hours:

[Vendor Setup: Wednesday, August 31, 9:00AM – 3:00PM]

Wednesday, August 31: 3:00 PM – 9:00 PM

Thursday, September 1: 8:00 AM – 4:00 PM

Friday, September 2: 8:00 AM – 5:00 PM

Saturday, September 3: 8:00 AM – 4:00 PM

Sunday, September 4: 8:00 AM – 5:00 PM

Monday, September 5: 8:00 AM – 5:00 PM

Tuesday, September 6: 9:00 AM – 1:30 PM

 

DAY ONE (Thursday, September 1st)

Grant Park Room

8:00 AM – 11:45 AM ISOBM Board Meeting
11:45 AM – 12:45 PM Student Orientation

 

Gold Room

Opening Ceremony

1:00 PM – 1:08 PM Welcome Video
1:08 PM – 1:13 PM Welcome & Opening Remarks Dr. James Radosevich, Congress President
1:13 PM – 1:16 PM Star Spangled Banner Megan McLaughlin
1:16 PM – 1:20 PM Illinois State Anthem Megan McLaughlin
1:20 PM – 1:25 PM Welcome Remarks Dr. Robert Barish, Vice Chancellor for Health Affairs, University of Illinois at Chicago
1:25 PM – 1:30 PM Introduction of Elliott Gunmaker & Ho Chunk Drummers Dr. James Radosevich, Congress President
1:30 PM – 1:50 PM Ho Chunk Drummers Performance

 

Rendevzous Area

1:50 PM – 2:00 PM Coffee Break


 

Gold Room

Keynote Presentations

Introductions: Dr. B. Aydogan (USA)

2:00 PM – 3:00 PM Targeting DNA Repair in Oncology Dr. P. Connell
3:00 PM – 4:00 PM Title TBA Dr. C. Croce
4:00 PM – 4:05 PM Closing Remarks Dr. James Radosevich, Congress President

 

Signature Room at the John Hancock Building

Opening Reception

5:45 PM VIPs meet at front entrance of hotel to board bus to Hancock Building
6:15 PM VIP bus arrives at Hancock Building
6:25 PM Attendees meet at front entrance of hotel to board buses to Hancock Building
6:45 PM First attendees arrive at Hancock Building — Receiving line at the Hancock Building on the 95th Floor Set Up (VIPs/ Board members)
7:00 PM – 9:30 PM Reception at the Hancock Building
9:30 PM – 10:00 PM Buses back to the Congress Hotel

 

 

 

 

DAY TWO (Friday, September 2nd)

Florentine Room

Scientific Session: Early Cancer Detection

Chairpersons: Dr. I. Cree (UK), Dr. C. Chapman (UK), Dr. A. Murray (UK)

8:00AM – 8:20AM Plasma cfDNA for Early Cancer Detection Dr. I. Cree
8:20AM – 8:40AM Autoantibodies in Lung Cancer Detection Dr. C. Chapman
8:40AM – 9:00AM Improvement in Performance of the EarlyCDT-Lung Test for Detection of Lung Cancer by Addition of Antigenic Biomarkers Dr. A. Murray
9:00AM – 9:20AM Lung Cancer Screening Initiative with Cuba Dr. K. Tossas-Milligan
9:20AM – 9:40AM A Novel Serological Marker for Pancreatic Cancer Dr. K. Taniuchi
9:40AM – 10:00AM Abbott ARCHITECT® AFP and PIVKA II for Early Detection of Hepatocellular Carcinoma Dr. P. Hemken

 

Gold Room

Scientific Session: Breast Cancer Biomarkers & Oncogenes

Chairpersons: Dr. V. Barak (Israel), Dr. H. Batool (Dubai), Dr. R. Molina (Spain)

8:00 AM – 8:30 AM Serum HER-2 as a Sensitive Tumor Marker in Breast Cancer Patients Dr. V. Barak
8:30 AM – 9:00 AM Immunotherapy in Endocrine Dependent Metastatic Breast Cancer Dr. A. Nicolini
9:00 AM – 9:20 AM Mutant p53 as a New Therapeutic Target for Breast Cancer Treatment Dr. M.J. Duffy
9:20 AM – 9:40 AM Circulating Levels of HER-2/neu Oncoprotein in Breast Cancer: Clinical Utility as Tumor Marker and in Therapy Monitoring Dr. R. Molina
9:40 AM – 10:00 AM Round Table Discussion

 

Rendevzous Area

10:00 AM – 10:30 AM Coffee Break

 

Florentine Room

Scientific Session: Tumor Hypoxia for Prediction of Response & Cancer Prognosis

Chairpersons: Dr. H. Halpern (USA), Dr. B. Aydogan (USA), Dr. B. Clifford (USA)

10:30AM – 11:00AM Tumor Hypoxia for Prediction of Response and Cancer Prognosis Dr. H. Halpern
11:00AM – 11:20AM Towards Oxygen-Guided Radiation Therapy Validation in Mice Model Dr. B. Epel
11:20AM – 11:40AM Using Electron Paramagnetic Resonance (EPR) to Identify Hypoxic Microenvironments in Tumors Expressing Hypoxia-Induced Proteins Dr. R. Miller
11:40AM – 12:00PM Imaging Transient Hypoxia in Tumors Using Fast Low-Rank Tensor Based EPR Imaging with Physical Priors Dr. B. Clifford

 

Gold Room

Scientific Session: Imaging as Biomarkers in Oncology

Chairpersons: Dr. B. Aydogan (USA)

10:30 AM – 10:50 AM Imaging as Cancer Biomarker for Diagnosis, Targeting, and Treatment Response Dr. B. Aydogan
10:50 AM – 11:25 AM X-ray Absorption, Fluorescence, and Luminescence as Potential Cancer Biomarkers Dr. P. LaRiviere
11:25 AM – 12:00 PM Advanced Diffusion MRI Techniques for Cancer Diagnosis and Treatment Monitoring Dr. J. Zhou

 

Plaza/Belmont/Francis I

12:00 PM – 12:45 PM Lunch

 

Gold Room

Keynote Presentations

Introductions: Dr. V. Barak (Israel), Dr. R. Molina (Spain)

12:45 PM – 1:45 PM Liver Cancer and Liver Cancer Biomarkers Dr. J. Marrero
1:45 PM – 2:30 PM Title TBA Dr. R. Bikkavilli
2:30 PM – 3:15 PM Oral Microbiome as Biomarkers for Head and Neck Cancers Dr. J. Schwartz

 

Rendevzous Area

3:15 PM –  3:30 PM Coffee Break

 

Florentine Room

Scientific Session: Circulating Cancer Cells & Biomarkers

        Chairpersons: Dr. S. Holdenrieder (Germany), Dr. J. Borgia (USA), Dr. L. Feldman (USA)

3:30 PM – 4:00 PM Serum biomarkers associated with disease progression in non-small cell lung cancer Dr. J. Borgia
4:00 PM – 4:20 PM Title TBA Dr. L. Feldman
4:20 PM – 4:40 PM The Effect of p85-sHER3 on Cancer Cell Growth and Migration: Requirement for Tenascin-C Dr. S.K. Rajpurohit

 

Gold Room

Scientific Session: Targeted Cancer Therapies & Stem cell

Chairpersons: Dr. J. Radosevich (USA), Dr. J. Chowdhury (USA), Dr. J. LaBelle (USA)

3:30 PM – 3:45 PM Nitric Oxide on Cancer Stem Cells Dr. J. Radosevich
3:45 PM – 4:00 PM Massive Oval (Stem) Cell Proliferation in Livers of Genetically Altered Mice after Aflatoxin Exposure Dr. S. Sell
4:00 PM – 4:15 PM Reactivation of Cancer Cell Death Using Novel Peptide Based Therapeutics Dr. J. LaBelle
4:15 PM – 4:30 PM IGF­1R Blockades for Gastrointestinal Cancer Cells with Mutated K­ras Gene Dr. Y. Adachi
4:30 PM – 4:45 PM Selected Growth Factors and Different Gastric Neoplasms in Humans Dr. B. Wojciech
4:45 PM – 5:00 PM A Rat Model for Nanoparticle Directed Treatment and Prevention of Liver Cancer Dr. S. Sell
5:00 PM – 5:15 PM Carboxypeptidase M (Cpm) Contributes Tumor Growth and Metastasis Related in Epithelial Mesenchymal Transition in Human Esophageal Carcinoma Dr. K. Kato


Poster Presentations at University of Illinois at Chicago (UIC), College of Dentistry

6:00PM Poster presenters/VIPs meet at front entrance of hotel to board bus to UIC
6:15PM Attendees meet at front entrance of hotel to board bus to UIC
6:30 PM – 9:30 PM Poster Session & Chicago Deep Dish Style Pizza

 

 

 

DAY THREE (Saturday, September 3rd)

Florentine Room

Scientific Session: Upper Respiratory Biology & Biomarkers

Chairpersons: Dr. L. Feldman (USA), Dr. P. Bonomi (USA), Dr. Jeff Borgia (USA)

8:00 AM – 8:45 AM Molecular Markers in Non-Small Cell Lung Cancer Dr. P. Bonomi
8:45 AM – 9:30 AM Validation of an Algorithm Using Tumor Markers, Clinical Data, and Imagine Techniques to Help in the Diagnosis and Histological Diagnosis of Lung Cancer Dr. R. Molina
9:30 AM – 9:45 AM Serial Tumor Marker Determination in Therapy Monitoring of Small Cell Lung Cancer Patients Dr. S. Holdenreider
9:45 AM – 10:00 AM Transcriptomic and Methylome Approaches to Identify Genetic Alterations in Esophageal Cancer of India Dr. I. Chattopadhyay

 

Gold Room

Scientific Session: Current Issues in Gastrointestinal & Gynecological Cancer

Chairpersons: Dr. M.J. Duffy (Ireland), Dr. L. Feldman (USA), Dr. K. Batool (USA)

8:00 AM – 8:15 AM Differential Levels of Hypoxia-Induced Factor-1a and 2a in Hepatocellular Carcinomas Dr. G. Chen
8:15 AM – 8:30 AM The Combination of uPAR(I) and Type IV Collagen Outperforms CEA as a Prognostic Biomarker in Primary Colorectal Cancer Dr. I. Christensen
8:30 AM – 8:45 AM Colorectal Cancer Associated Biomarkers: The Effect of Bowel Preparation Dr. N. Pedersen
8:45 AM – 9:00 AM Increased Serological Protein Biomarker Levels at Diagnostic Bowel Endoscopy Are Associated with Risk of Being Diagnosed with Subsequent Primary Malignancy Dr. T. Piper
9:00 AM – 9:15 AM Glad-PCR Assay of DNA Methylation Markers Associated with Colorectal Cancer Dr. A. Evdokimov
9:15 AM – 9:30 AM Prototype Biomarker Panel Algorithms for Aiding in Early Colorectal Cancer (CRC) Detection Dr. G. Davis
9:30 AM – 9:45 AM A Reflex Algorithm for Identifying Presence of Extra-Colonic Cancers in False-Positive CRC Screened Subjects Dr. S. Gawel
9:45 AM – 10:00 AM Epigenetic Profiling of Circulating Cell Free Nucleosomes: A Novel Approach to Reducing the Impact of Colorectal Cancer Dr. M. Eccleston
10:15AM – 10:30AM Biomarker & Early Detection of Ovarian Cancer Dr. A. Barua

 

Rendevzous Area

10:15 AM – 10:30 AM Coffee Break

 

Florentine Room

Session Title: Targeted Immunotherapies

Chairpersons: Dr. M. Chechlinska (Poland), Dr. J. Labelle (USA)

10:30AM – 10:45AM Deletion of DNA-Binding Inhibitor Id3 Enhances Anticancer Function of T Cells by Inducing Th9 Cells Dr. D. Zhang
10:45AM – 11:00AM An Anti-PSMA Immunotoxin Induces Apoptosis and Efficiently Eliminates Prostate Cancer Cells in Combination with ABT-737 Dr. M. Michalska

 

Gold Room

Scientific Session: Liquid Biopsies and Serum Assays

Chairpersons: Dr. C. Mandal (India), Dr. Borgia (USA), Dr. Thomas (USA)

10:30 AM – 10:45 AM Targeting Cellular Cholesterol Might Be a Therapeutic Strategy for Breast Cancer Bone Metastasis Dr. C. Mandal
10:45 AM- 11:00 AM Early Detection of Neoplasia Dr. M. Wilhelmsen

 

Gold Room

Keynote Presentation

Introduction: Dr. C. Maki (USA)

11:00AM – 12:00PM Evolving Role of Precision Medicine to Guide Decision Making in Oncology Dr. A. Dudek

 

Plaza/Belmont/Francis I

12:00 PM – 12:45 PM Lunch

Gold Room

Keynote Presentations

Introductions: R. Molina (Spain), V. Barak (Israel)

12:45 PM – 1:45 PM Discovery of Cyclic GMP and Nitric Oxide in Cell Signaling and Their Role in Drug Development Dr. F. Murad
1:45 PM – 2:30 PM Vitamin D Receptor and Cancer Dr. M. Kadakia
2:30 PM – 3:00 PM Title TBA Dr. G. Adami

 

Rendevzous Area

3:00 PM –  3:15 PM Coffee Break

 

Florentine Room

Scientific Session: Circulating Tumor Nucleosomes, DNA & Genetics

Chairpersons: Dr. S. Holderieder (Germany), Dr. E. Yoruker (Turkey), Dr. S. Sell (USA)

3:15 PM – 3:30 PM Circulating Cell Free Nucleosome Levels Are Not Affected by Stage of CRC, Comorbidity or Demographic Variables Dr. L. Rasmussen
3:30 PM – 3:45 PM Targeted Exome Sequencing of Cancer-Related Genes in Human Cancers Using the Semiconductor Sequencer Dr. Y. Sasaki
3:45 PM – 4:00 PM Phenothiazines Modulate Chromatin-Related DNA Repair Signaling in Tumors Dr. P. Hååg
4:00 PM – 4:15 PM Significance Estimation of EGFR and Their Polymorphisms in Non-Small Cell Lung Cancer Dr. V. Jurisic

 

Gold Room

Session Title: Hot Topics in Cancer Research

Chairpersons: Dr. Malaiyanda (USA), Dr. Patel (India), Dr. J. Chowdhury (USA)

3:15 PM – 3:30 PM Diagnostic Value of Interleukin-31and 33 in Endometrial Cancer Dr. Xi Zeng
3:30 PM – 3:45 PM Biopsy Levels of miR-375, miR-200b and miR-29c Associated with Prognosis of Head and Neck Cancers Dr. Jaromir Gumulec
3:45 PM – 4:00 PM The Role of Human DNA Repair Protein APE1/Ref-1 in Transcriptional Regulation of Genes Involved in Cancer Development Dr. Milena Bazlekowa
4:00 PM – 4:15 PM Anticancer Effects Elicited by Combination of Rubus Extract with Phthalocyanine Photosensitiser on MCF-7 Cells Dr. G. Blassan

 

Odyssey Boat Cruise at Navy Pier

5:00 PM Meet at front entrance of hotel to board bus to Navy Pier
7:00 PM Last boarding of ship
7:00 PM – 11:00 PM Lake Michigan Dinner / Dance Cruise
11:00 PM- 12:00 AM Buses back to hotel

 

 

 

DAY FOUR (Sunday, September 4th)

Florentine Room

Session Title: Clinical Applications of Cancer Biomarkers

Chairpersons: Dr. Sanchez-Carbayo (Spain), Dr. R. Molina (Spain), Dr. H. Batool (USA)

8:30 AM – 9:00 AM HE4 a New Tumor Marker in Ovarian Cancer: Controversies and Clinical Applications Dr. R. Molina
9:00 AM – 9:15AM Soluble Epha2 Has a Potential of Novel Serum Biomarker for Malignant Cancers Dr. T. Kondo
9:15 AM – 9:30 AM Protocol: Detection of False FIT Negative Subjects by Combinations of Blood-Based Biomarkers Dr. H. Nielsen
9:30 AM – 9:45 AM PMF-1 Methylation Is a Prognostic and Predictive Biomarker of Sunitinib Response in Patients with Kidney Cancer Dr. M. Sánchez-Carbayo
9:45 AM – 10:00 AM Diagnostic Performance of Tumor Makers AFP and PIVKA-II in Chinese Hepatocellular Carcinoma Patients Dr. X. Wang

 

Gold Room

Session Title: Tumor Immunology

            Chairpersons: Dr. Nicolini (Italy), Dr. Malaiyandi (USA), Dr. Nap (Netherlands)

8:30 AM – 8:45 AM MicroRNAs as Molecular Markers in Central Nervous System Lymphomas Dr. M. Chechlinska
8:45 AM – 9:00 AM Investigation of Putative Molecular Marker in Human Papillomavirus Associated Cervical Cancer in Indian Population Dr. M. Bharadwaj
9:00 AM – 9:15 AM Evaluation of an Improved Version of the Arocell TK 210 ELISA for Determining TK1 Protein Levels In Serum Samples Dr. K. Jagarlamudi
9:15 AM – 9:30 AM Human Papillomavirus, an Oncogenic SUMO Wrestler Dr. A. Nag
9:30 AM – 9:45 AM Investigation of Snps/Haplotypes as Biomarkers to Tobacco Associated Oral Squamous Cell Carcinoma in Indian Population Dr. M. Bharadwaj
9:45 AM – 10:00 AM The Influence of PSA Autoantibodies in Prostate Cancer Dr. K. Nakajima

 

Rendevzous Area

10:00 AM – 10:30 AM Coffee Break

 

Gold Room

Session Title:  Current Topics in Liver & Pancreatic Carcinomas

            Chairpersons: Dr. Bassiony (Egypt), Dr. De Vitto (Brazil), Dr. Nag (India)

10:30 AM – 10:45 AM A Novel Biomarker for Early Diagnosis of Hepatocellular Carcinoma Dr. N. Koshikawa
10:45 AM – 11:00 AM Cytokine Induction by Trabedersen (OT-101) Treatment: Results from a Phase I/II Trial in Pancreatic Cancer Patients Dr. L. Hwang

 

Gold Room

Keynote Presentation

Introduction: Dr. Malaiyandi (USA)

11:00 AM – 12:00 PM Botanicals as Natural Alternatives to Hormone Replacement Therapy: Role in Breast Cancer Prevention? Dr. J. Bolton

 

Plaza/Belmont/Francis I

12:00 PM – 1:00 PM Lunch

 

Gold Room

Keynote Presentation

Introduction: Dr. K. Dineley (USA)

1:00 PM – 2:00 PM Wnt5a Modulates Vascularization of Non-Small Cell Lung Cancer Dr. J. Pongracz

 

Rendevzous Area

2:00 PM –  2:30 PM Coffee Break

 

Gold Room

Scientific Session: European Group on Tumour Markers (EGTM)

Chairpersons: Dr. V. Barak (Israel), Dr. R. Molina (Spain), Dr. J. Radosevich (USA)

2:30 PM – 3:00 PM The Clinical Role of the Immune Biomarker sIL2R in Head and Neck Cancer Dr. V. Barak
3:00 PM – 3:30 PM Biomarkers in Colorectal Cancer: Which Ones are Clinically Useful? Dr. M.J. Duffy
3:30 PM – 4:00 PM Tumor Markers Use for the Differential Diagnostic of Effusions Dr. R. Molina &

Dr. Trape

4:00 PM – 4:30 PM Biomarkers: Best Assays to Assess Response to New Therapies and Provide Prognosis in Melanoma Patients Dr. V. Barak

 

Plaza/Belmont/Francis I

4:30 PM – 6:00 PM Hor D’oeuvers

 

Gold Room

6:00 PM – 8:00 PM General Assembly (Chaired by Dr. R. Molina)

 

 

DAY FIVE (Monday, September 5th)

Gold Room

Session Title: New Models in Cancer Research

Chairpersons: Dr. K. Batul (Dubai), Dr. C. Chapman (UK), Dr. C. Maki (USA)

9:00 AM – 9:30 AM Diabetes, metformin and oral precancer progression Dr. A. Schneider
9:30 AM – 10:00 AM Computational simulation models containing NSCLC patient genomic signatures predict drug responder status to anti-PD-1 immunotherapy Dr. K. Brogden
10:00 AM – 10:30 AM Using Pseudomonas Exotoxin T (ExoT) to target apoptotic compensatory proliferation signaling in cancer Dr. S. Shafikhani

 

Rendevzous Area

10:30 AM –  11:00 AM Coffee Break

 

Gold Room

Keynote Presentation

Introduction: Dr. S. Holdenreider (Germany)

11:00AM – 12:00PM Mechanism-Based Repurposing of Neurodegenerative Disease Drugs for Breast Cancer Treatment Dr. A. Rana

 

Plaza/Belmont/Francis I

12:00 PM – 1:00 PM Lunch

 

Gold Room

Keynote Presentations

Introductions: Dr. R. Molina (Spain), Dr. V. Barak (Israel), Dr. Patel (India), Dr. Borgia (USA)

1:00 PM – 2:00 PM Developing Precision Medicine for Lung Cancer Dr. J. Minna
2:00 PM – 2:30 PM Title TBA Dr. R. Winn
2:30 PM – 3:00 PM Cold Environment Is a Risk Factor for Cancer Dr. C. Mandal

 

Rendevzous Area

3:00 PM –  3:30 PM Coffee Break

 

Gold Room

Session Title: Mechanisms and Development of New Cancer Agents

Chairpersons: Dr. M.J. Duffy (Ireland), Dr. C. Maki (USA), Dr. J. Chowdhury (USA)

3:30 PM – 3:45 PM Crosstalk Between p53 and the IGF-IR/AKT mTORCI Pathway Reduces the Effectiveness of IGF-IR Dr. C. Maki
3:45 PM – 4:00 PM TPS an Appropriate Marker for the Follow-up Monitoring of Breast Cancer Patients After Radical Surgery Dr. R. Kucera

 

Rendevzous Area

7:00 PM –  11:00 PM Gala Dinner

 

DAY SIX (Tuesday, September 6th)

Grant Park Room

8:00AM – 9:00AM Executive ISOBM Board Meeting

 

Florentine Room

Scientific Session:  Biomarkers in Prostate Cancer

Chairpersons: Dr. R. Szmulewitz (USA)

9:00 AM – 9:30 AM Hox Protein Regulators as Biomarkers in Prostate Cancer Dr. D. Vander Griend
9:30 AM – 10:00 AM Molecular Biomarkers in Castration Resistant Prostate Cancer: What We Learn From the Blood Dr. R. Szmulewitz

 

Rendevzous Area

10:00 AM –  10:30 AM Coffee Break

 

Florentine Room

Scientific Session:  Radiomics & Radiogenomics as Biomarkers in Precision Medicine

Chairpersons: Dr. B. Aydogan (USA), Dr. H. Li (USA)

10:30AM – 11:00AM Radiomics of Breast Cancer and Associated Challenges with Big Data Dr. K. Drukker
11:00AM – 11:30AM Radiomics in Breast Cancer Risk Assessment Dr. H. Li
11:30AM – 11:45AM Deep Learning in the Radiomics of Breast Cancer Imaging Dr. B. Huynh

 

Florentine Room

12:00 PM – 12:30 PM Closing Ceremony

 

Plaza/Belmont/Francis I

12:30 PM – 1:30 PM Hor D’oeuvers

 

Grant Park Room

1:30 PM Executive ISOBM Board Meeting

Floor Plan 

Print Friendly
REGISTER FOR ISOBM NOWBuy Sailing with the Scientist TicketsSubmit Your Abstract NowSubmit Your Poster HereSubmit Your Flight Information

Director’s Message

Juel 2

I am Dr. Juel Chowdhury, M.D. I have had the opportunity to work for oncology research with James A Radosvich, PhD and have had so many fulfilling experiences. Through these experiences, I’ve been able to work on some amazing projects with amazing people. Cancer has been prevalent all over the world, so I am proud to give such a great contribution that works to eliminate all types of cancer.

Being part of the ISOBM Organization and work closely with world class scientist is one of the best experiences.

Looking forward to meeting with you at this unique event,

Cordially,

 

 

Dr.Juel Chowdhury, M.D.

Joel-Signature

Director of the ISOBM 2016 Congress

Chicago,IL

USA

juel@isobm2016congress.com

Print Friendly
Chicago
37°
haze
humidity: 61%
wind: 7mph WSW
H 37 • L 32
31°
Wed
36°
Thu
38°
Fri
34°
Sat
40°
Sun
Weather from OpenWeatherMap
UI Health
Sponsors
Translate »

ISOBM 2016 Abbott Prize winner Dr. John Minna, M.D